Carnitine deficiency in epileptic children treated with a diversity of anti-epileptic regimens.

Related Articles

Carnitine deficiency in epileptic children treated with a diversity of anti-epileptic regimens.

Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):37

Authors: El Mously S, Abdel Ghaffar H, Magdy R, Hamza S, Mansour M

Abstract
Background: Carnitine deficiency is relatively common in epileptic patients. The risk factors reported include the combination of valproic acid with other antiepileptic drugs (AEDs), young age, multiple neurologic disabilities, non-ambulatory status, and being underweight.
Objectives: To study the level of carnitine deficiency and its associated risk factors among a group of children with idiopathic epilepsy treated with different AEDs.
Patients and methods: Fifty children with idiopathic epilepsy and 40 age-matched controls were enrolled. For all, serum carnitine level was measured by enzyme-linked immune sorbent assay (ELISA).
Results: The mean carnitine level was lower in cases compared to controls (p = 0.04). Patients receiving monotherapy treatment had a high percentage of carnitine deficiency compared to controls (p = 0.04). Patients receiving valproate with other AEDs had a lower level of carnitine compared to controls (p = 0.03). The age of the patients, the duration of treatment, and the doses of different AEDs were not risk factors for carnitine deficiency.
Conclusions: Carnitine deficiency is common in our population, and the use of valproate with other AEDs is considered the most important risk factor for it in epileptic children.

PMID: 30546248 [PubMed]

from A via a.sfakia on Inoreader https://ift.tt/2QtedZk